leadf
logo-loader

Sahel Oncology

Receive alerts
Market:
Unlisted
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Sahel Oncology is actively pursuing drug development in the field of oncology, with key products that have shown promising results in variety of cancer types. The main aim of Sahel is to apply therapies that improve overall survival , rather than tumor size or progression free survival. Sahel has dedicated last 8 years in experimental therapeutics and designed several clinical trials, including trial to treat patients with brain cancer, which has received orphan drug designation approval by the FDA. To learn more about the patented technology and products, please see: